|
KIAA0831 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.587400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.312570E-01 |
| Normal-vs-Stage2 |
6.867000E-01 |
| Normal-vs-Stage3 |
2.283300E-03 |
| Normal-vs-Stage4 |
7.226800E-04 |
| Stage1-vs-Stage2 |
1.738360E-01 |
| Stage1-vs-Stage3 |
2.61270000001534E-06 |
| Stage1-vs-Stage4 |
1.65585999999385E-05 |
| Stage2-vs-Stage3 |
1.248030E-01 |
| Stage2-vs-Stage4 |
4.176200E-02 |
| Stage3-vs-Stage4 |
4.724000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.994030E-01 |
| Normal-vs-AfricanAmerican |
4.728400E-01 |
| Normal-vs-Asian |
1.184230E-01 |
| Caucasian-vs-AfricanAmerican |
1.260590E-01 |
| Caucasian-vs-Asian |
3.996100E-02 |
| AfricanAmerican-vs-Asian |
1.778990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.563400E-01 |
| Normal-vs-Female |
7.689800E-01 |
| Male-vs-Female |
4.347600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.221600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.400400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.895500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.657020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.928800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.134600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.142200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.498100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.740300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.840400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.242200E-03 |
| Normal-vs-Grade 2 |
1.477050E-01 |
| Normal-vs-Grade 3 |
4.433600E-02 |
| Normal-vs-Grade 4 |
5.86270000324518E-08 |
| Grade 1-vs-Grade 2 |
2.422600E-03 |
| Grade 1-vs-Grade 3 |
2.10720000004549E-06 |
| Grade 1-vs-Grade 4 |
1.237570E-04 |
| Grade 2-vs-Grade 3 |
4.242900E-04 |
| Grade 2-vs-Grade 4 |
4.38939995461851E-11 |
| Grade 3-vs-Grade 4 |
2.759600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.409600E-02 |
| Normal-vs-ccB subtype |
3.350300E-02 |
| ccA subtype-vs-ccB subtype |
1.181370E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.279000E-01 |
| Normal-vs-N1 |
1.59070000005368E-06 |
| N0-vs-N1 |
1.169440E-04 |
|
|
